Amgen | AMGN - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
AbbVie USD 3.84B 205M 2026-09
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
ALKERMES USD 196.64M 67.96M 2026-06
Amgen USD 1.72B 134M 2026-06
Biogen USD 752M 42.3M 2026-09
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Coherus Biosciences USD 15M 6.26M 2025-12
Eli Lilly USD 3.12B 305M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Genmab DKK 205M 39M 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Glaxosmithkline GBP 2.38B 264M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
J&J USD 6.25B 168M 2026-09
Merck USD 2.86B 25M 2026-09
Moderna USD 216M 43M 2026-06
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Novartis USD 3.08B 163M 2026-09
Novartis USD 3.08B 58M 2026-09
Pfizer USD 3.28B 132M 2026-09
PTC Therapeutics USD 80.63M 6.74M 2026-06
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
Sarepta Therapeutics USD 107.6M 53.57M 2026-06
Takeda JPY 271.71B 14.8B 2026-09
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06
Ultragenyx Pharmaceutical USD 88M 0 2026-06
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09